Jeffrey R. Dahlen

Papers

Total Citations

235

H-Index

About

Jeffrey R. Dahlen is a leading translational researcher whose work has fundamentally advanced the early detection and management of acute ischemic stroke. His most influential contribution, the landmark 2003 paper "Early Biomarkers of Stroke," has garnered over 235 citations and established a critical framework for identifying blood-based biomarkers that can rapidly distinguish ischemic stroke from hemorrhagic stroke in emergency settings. This work directly addressed a major clinical bottleneck: the limited sensitivity of CT scans in detecting ischemic events, which often delays life-saving treatment. By pioneering the search for rapid diagnostic assays, Dahlen helped lay the groundwork for point-of-care tools that can accelerate thrombolytic therapy decisions. His research sits at the intersection of neurology, emergency medicine, and molecular diagnostics, with lasting impact on how clinicians triage and treat stroke patients. Dahlen’s contributions continue to influence ongoing efforts to reduce the time-to-treatment gap, making him a key figure in the push toward precision emergency medicine.